These independent CME/CE activities are supported by educational grants from

Biogen Idec

Genentech, Inc.

Teva Neuroscience.

The Advanced Certificate Program in
Multiple Sclerosis Management II
  1. Curriculum III
  2. Curriculum II
  3. Curriculum I
  4. Full Course List
Co-Chairs
faculty image
Fred D. Lublin, MD
  • Saunders Family Professor of Neurology
  • The Corinne Goldsmith Dickinson Center for Multiple Sclerosis
  • Mount Sinai School of Medicine
  • New York, NY
    • faculty image
    Aaron E. Miller, MD
  • Professor of Neurology and Medical Director
  • The Corinne Goldsmith Dickinson Center for Multiple Sclerosis
  • Mount Sinai School of Medicine
  • New York, NY
    • The past few years have seen exciting developments in understanding the pathophysiology and disease processes of MS and new diagnostic methodologies. Many emerging therapeutic agents are now in development with new data rapidly emerging.

    Curriculum I courses present an overview of diagnostic and management strategies for MS patients, focusing on cutting-edge topics. Curriculum II presents more advanced courses that build on new scientific developments and the topics covered in Curriculum I.

    Featuring the very latest state-of-the-science information about MS diagnosis and treatment, this free online curriculum offers CME, CE, and CPE credit to neurologists and other clinicians who care for patients with MS.

    New curriculum courses are continuously made available online throughout the year. Complete all courses by July 2010, and receive a certificate of advanced study.
  • Apply knowledge of magnetic resonance imaging (MRI) and markers to diagnose, monitor intervention, and determine disease progression to formulate treatment strategies for patients with MS.
  • Assess the etiology, pathophysiology, and diagnosis of MS in order to determine appropriate treatment approaches that improve patient outcomes.
  • Evaluate the immune and inflammatory response in MS and potential targets for therapeutic intervention to select optimal therapies and strategies for the treatment of MS patients.
  • Determine the appropriate use of current and emerging MS agents in treatment strategies for MS patients that improve outcomes through knowledge of their MOA, efficacy, and safety.
  • Customize therapies for MS patients based on an understanding of their form of MS, symptoms, concomitant medications, comorbidities, and compliance to improve their response.
  • Integrate therapies that offer improved compliance based on knowledge of the various agents, their mode of administration, and patients’ preferences to ensure more successful treatment regimens.
    • Current FDA approved treatment
    • Emerging Therapies:
      • Emerging immunomodulatory agents
      • Chemotherapeutic agents
      • Monoclonal antibodies targeting molecules on T cells, B cells, and other immune cells
      • Agents affecting the blood brin barrier
      • Agents affecting lymphocyte trafficking
    • Clinical trials versus real-world treatment regimens
    • Customizing MS therapies
    • Comparison of current agents
    • Strategies for treatment-related side-effect management
    • Strategies for managing suboptimal responders
    • Injectable versus oral MS therapies
    • Treatments for trigeminal neuralgia and other types of pain in MS
    • Immunopathology and inflammation in MS
    • Mechanism for altering the natural history of MS
    • MS differential diagnosis
    • Radiologically isolated syndrome
    • Advances in the role of MRIs in MS
    • Current and emerging MS treatments
    • Effects of statins in MS
    • Role of vitamin D in MS susceptibility and treatment
    • Monitoring disease progression, side effects of therapy, and adherence to treatment
    • Suboptimal response to therapy: subsequent management
    • Case studies—expert insights into challenging MS cases

    Target Audience

    These activities are designed for neurologists and other clinicians who specialize in and care for patients with multiple sclerosis.

     

    Activity Goal

    The goal of these CME/CE activities is to examine current and emerging strategies for treating and managing patients with multiple sclerosis.